152 related articles for article (PubMed ID: 35157269)
1. Preparation of Immune and Synthetic VNAR Libraries as Sources of High-Affinity Binders.
Gasperin-Bulbarela J; Cabanillas-Bernal O; Dueñas S; Licea-Navarro AF
Methods Mol Biol; 2022; 2446():71-93. PubMed ID: 35157269
[TBL] [Abstract][Full Text] [Related]
2. Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3.
Cabanillas-Bernal O; Dueñas S; Ayala-Avila M; Rucavado A; Escalante T; Licea-Navarro AF
PLoS One; 2019; 14(6):e0213394. PubMed ID: 31206542
[TBL] [Abstract][Full Text] [Related]
3. Shark Attack: high affinity binding proteins derived from shark vNAR domains by stepwise in vitro affinity maturation.
Zielonka S; Weber N; Becker S; Doerner A; Christmann A; Christmann C; Uth C; Fritz J; Schäfer E; Steinmann B; Empting M; Ockelmann P; Lierz M; Kolmar H
J Biotechnol; 2014 Dec; 191():236-45. PubMed ID: 24862193
[TBL] [Abstract][Full Text] [Related]
4. Exploring shark VNAR antibody against infectious diseases using phage display technology.
Lim HT; Kok BH; Leow CY; Leow CH
Fish Shellfish Immunol; 2023 Sep; 140():108986. PubMed ID: 37541634
[TBL] [Abstract][Full Text] [Related]
5. Selection and Characterization of Anti-idiotypic Shark Antibody Domains.
Könning D; Zielonka S; Kaempffe A; Jäger S; Kolmar H; Schröter C
Methods Mol Biol; 2020; 2070():191-209. PubMed ID: 31625097
[TBL] [Abstract][Full Text] [Related]
6. Construction of Histidine-Enriched Shark IgNAR Variable Domain Antibody Libraries for the Isolation of pH-Sensitive vNAR Fragments.
Könning D; Hinz S; Grzeschik J; Schröter C; Krah S; Zielonka S; Kolmar H
Methods Mol Biol; 2018; 1827():109-127. PubMed ID: 30196494
[TBL] [Abstract][Full Text] [Related]
7. Construction and next-generation sequencing analysis of a large phage-displayed V
Feng M; Bian H; Wu X; Fu T; Fu Y; Hong J; Fleming BD; Flajnik MF; Ho M
Antib Ther; 2019 Jan; 2(1):1-11. PubMed ID: 30627698
[No Abstract] [Full Text] [Related]
8. Generation of Semi-Synthetic Shark IgNAR Single-Domain Antibody Libraries.
Grzeschik J; Könning D; Hinz SC; Krah S; Schröter C; Empting M; Kolmar H; Zielonka S
Methods Mol Biol; 2018; 1701():147-167. PubMed ID: 29116504
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of malaria PfHRP2 specific V
Leow CH; Fischer K; Leow CY; Braet K; Cheng Q; McCarthy J
Malar J; 2018 Oct; 17(1):383. PubMed ID: 30355309
[TBL] [Abstract][Full Text] [Related]
10. Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders.
Könning D; Rhiel L; Empting M; Grzeschik J; Sellmann C; Schröter C; Zielonka S; Dickgießer S; Pirzer T; Yanakieva D; Becker S; Kolmar H
Sci Rep; 2017 Aug; 7(1):9676. PubMed ID: 28852148
[TBL] [Abstract][Full Text] [Related]
11. Ancient species offers contemporary therapeutics: an update on shark V
English H; Hong J; Ho M
Antib Ther; 2020 Jan; 3(1):1-9. PubMed ID: 32118195
[TBL] [Abstract][Full Text] [Related]
12. Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies.
Macarrón Palacios A; Grzeschik J; Deweid L; Krah S; Zielonka S; Rösner T; Peipp M; Valerius T; Kolmar H
Front Immunol; 2020; 11():560244. PubMed ID: 33324393
[TBL] [Abstract][Full Text] [Related]
13. Construction of Semisynthetic Shark vNAR Yeast Surface Display Antibody Libraries.
Kolmar H; Grzeschik J; Könning D; Krah S; Zielonka S
Methods Mol Biol; 2023; 2702():227-243. PubMed ID: 37679622
[TBL] [Abstract][Full Text] [Related]
14. Shark VNAR phage display libraries: An alternative source for therapeutic and diagnostic recombinant antibody fragments.
Manoutcharian K; Gevorkian G
Fish Shellfish Immunol; 2023 Jul; 138():108808. PubMed ID: 37169114
[TBL] [Abstract][Full Text] [Related]
15. Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2.
Cabanillas-Bernal O; Valdovinos-Navarro BJ; Cervantes-Luevano KE; Sanchez-Campos N; Licea-Navarro AF
Front Immunol; 2023; 14():1257042. PubMed ID: 37753081
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties.
Steven J; Ubah OC; Buschhaus M; Kovaleva M; Ferguson L; Porter AJ; Barelle CJ
Methods Mol Biol; 2020; 2070():115-142. PubMed ID: 31625093
[TBL] [Abstract][Full Text] [Related]
17. Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (
Zhao L; Chen M; Wang X; Kang S; Xue W; Li Z
Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621957
[TBL] [Abstract][Full Text] [Related]
18. Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents.
Buschhaus MJ; Becker S; Porter AJ; Barelle CJ
Protein Eng Des Sel; 2019 Dec; 32(9):385-399. PubMed ID: 32119084
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis.
Kovaleva M; Johnson K; Steven J; Barelle CJ; Porter A
Front Immunol; 2017; 8():1121. PubMed ID: 28993766
[TBL] [Abstract][Full Text] [Related]
20. Generation of VNAR Libraries from Immunized Sharks and Selection of Target-Specific Clones.
Dooley H
Methods Mol Biol; 2022; 2421():57-72. PubMed ID: 34870811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
